Journal of Clinical Investigation · 1985 · 314 citations · 22 references
Active Visceral LeishmaniasisImmunodeficienciesMucosal LeishmaniasisImmune RegulationImmunologyPathologyImmune SystemImmunotherapyVisceral LeishmaniasisInflammationImmunopathologyAutoimmune DiseaseGamma InterferonParasitic ProtozoaAutoimmunityImmunologic DiseaseCytokineInterleukin 2Medicine
The lymphocytes from eight patients with active visceral leishmaniasis (VL), a disease associated with marked immunologic dysfunction, were examined for ability to produce interleukin 2 (IL-2) and gamma interferon during in vitro cultivation. It was found that both IL-2 and gamma interferon production, in response to leishmania antigen, was absent during the active disease, but was restored after successful chemotherapy. Untreated VL patients produced IL-2 and gamma interferon when stimulated with phytohemagglutinin (PHA). Six patients with either active cutaneous or mucosal leishmaniasis, a disease not associated with immunosuppression, showed high levels of gamma interferon in response to leishmania antigen and PHA. Since IL-2 and gamma interferon have been shown to have important roles in the immune response and in the killing of leishmania, their absence may represent a key defect in the immune response in VL.
22
Thymoma production of T cell growth factor (Interleukin 2).
Jeremy Farrar, J Fuller-Farrar, P L Simon et al. · The Journal of Immunology · 1980 · 482 citations · Full text
Henry W. Murray, Berish Y. Rubin, Constance D. Rothermel · Journal of Clinical Investigation · 1983 · 404 citations · Full text